IL10 and non-small cell lung carcinoma: In NSCLC, increased IL-10 expression by TAMs correlates with more advanced stages of the disease, the presence of lymph node metastases, pleural invasion, lymphovascular spread, and lower differentiation of tumor cells, underscoring the significance of TAM-derived IL-10 in disease progression.97